These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 23586

  • 1. [Bronchial obstruction and its differentiated therapy in bronchopulmonary diseases].
    Zamotaev IP, Shul'gin AV, Maksimova LN, Bulycheva NA, Golub' GA.
    Sov Med; 1977 Dec; (12):19-23. PubMed ID: 23586
    [No Abstract] [Full Text] [Related]

  • 2. [Association of bronchodilator agents and mucolytics in aerosol therapy of chronic bronchopathies].
    Olivieri D, Brancaccio L, Bocchino M.
    Handchirurgie; 1974 Dec; 29(2):138-46. PubMed ID: 4452486
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.
    Svedmyr N, Malmberg R, Thiringer G.
    Scand J Respir Dis; 1972 Dec; 53(5):302-13. PubMed ID: 4404808
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of the effectiveness of bricanyl].
    Ubaĭdullaev AM, Makhmudova DKh, Iakimova MA, Islamkhodzhaev PS.
    Ter Arkh; 1980 Dec; 52(11):130-2. PubMed ID: 6110247
    [No Abstract] [Full Text] [Related]

  • 6. [Drug tolerance in asthmatic patients treated with beta adrenergic drugs].
    Herjavecz I, Böszórményi, Nagy G, Szeitz A, Debreczeni L.
    Orv Hetil; 1985 Sep 29; 126(39):2401-4, 2407. PubMed ID: 2864677
    [No Abstract] [Full Text] [Related]

  • 7. [The interrelation of autonomic homeostasis and the broncho-obstructive syndrome in patients with chronic bronchitis and the effect of broncholytic therapy with sal'tos].
    Sokolov AV, Iakushina MS, Iakushin SS.
    Ter Arkh; 1996 Sep 29; 68(11):70-2. PubMed ID: 9045388
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of bronchial obstruction with beta-2-mimetic and anticholinergic agents in aerosol. Advantages of the combination of both groups of pharmaceuticals].
    Minette A, Marcq M.
    Rev Inst Hyg Mines (Hasselt); 1980 Sep 29; 35(2):85-114. PubMed ID: 6111836
    [Abstract] [Full Text] [Related]

  • 9. [Critical evaluation of a long acting bronchodilator agent in the treatment of asthma and chronic bronchial diseases].
    Paramelle F, Paramelle B.
    Therapeutique; 1973 Nov 29; 49(9):591-4. PubMed ID: 4600038
    [No Abstract] [Full Text] [Related]

  • 10. Double-blind comparative trial of two metered bronchodilator aerosols.
    Gent PN, Hughes DT, Nisbet IG, Pearson SB, Sturgeon JG.
    Br J Clin Pract; 1968 Nov 11; 22(11):479-81. PubMed ID: 4880250
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Indication and technique of treatment with aerosols of drugs in a fine mist in long term therapy of chronic bronchitis (author's transl)].
    Herzog H, Keller R.
    Med Klin; 1973 Dec 07; 68(49):1610-7. PubMed ID: 4204452
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
    Emel'ianov AV, Shevelev SE, Shubin SA, Sinitsina TM, Fedoseev GB.
    Klin Med (Mosk); 1998 Dec 07; 76(7):38-9. PubMed ID: 9742777
    [No Abstract] [Full Text] [Related]

  • 15. [Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction].
    Ulmer WT, Dorsch J, Iravani J, Schüler KG, Stempel G, Vastag E.
    Arzneimittelforschung; 1973 Mar 07; 23(3):468-76. PubMed ID: 4740138
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
    Shim C.
    Clin Chest Med; 1984 Dec 07; 5(4):659-68. PubMed ID: 6151440
    [Abstract] [Full Text] [Related]

  • 18. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
    Dano P, Falholt W.
    Ugeskr Laeger; 1971 Apr 16; 133(15):685-8. PubMed ID: 4396922
    [No Abstract] [Full Text] [Related]

  • 19. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
    Verstraeten JM.
    Acta Tuberc Pneumol Belg; 1976 Apr 16; 67(3-4):130-55. PubMed ID: 138352
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of chronic obstructive bronchopulmonary disease in the aged.
    Lipman WH.
    West Med Med J West; 1967 Apr 16; 8(3):73-5. PubMed ID: 6072167
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.